The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

A study found that GLP-1 RA use is linked to risks for retained gastric contents during single endoscopic procedures but not ...

Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual fibroblast growth factor 21 ...

“The average woman gains about six to seven pounds during this menopausal transitional period,” says Daniel H. Bessesen, MD, ...

The ability to act upon more than one disease and disorder has led to the GLP-1 analogues market has been getting a ...

Over 137 million US adults are eligible for semaglutide, driven by expanding indications for diabetes, weight management, and ...

As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.

Following underperformance in Q2 2024, the Franklin Biotechnology Discovery Fund returned to strength in Q3 2024. Click here ...

The fund posted returns of 6.75% (Institutional shares) and 6.68%(Investor A shares, without sales charge) for the third ...

(HealthDay News) — For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE), ...